Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Eur J Epidemiol. 2019 Sep 26;34(11):997–1011. doi: 10.1007/s10654-019-00565-8

Table 1.

Age-adjusted demographics of study participants by cohort in 1994 for NHS, 1999 for NHSII, and 1990 for HPFS

NHS (n = 114,419) NHSII (n = 115,813) HPFS (n = 50,223)



Incident glioma cases (n = 208) Overall cohort Incident glioma cases (n = 84) Overall cohort Incident glioma cases (n = 191) Overall cohort
Age, years (mean ± SD) 62.4 (6.7) 60.7 (7.2) 46.3 (4.7) 44.7 (4.7) 59.4 (8.9) 58.4 (9.8)
BMI, kg/m2 (mean ± SD) 26.5 (3.9) 26.5 (5.2) 26.1 (2.6) 26.6 (6.3) 26.3 (3.0) 25.7 (3.4)
Smoking status (%)
 Never smoker 46 43 66 64 46 45
 Former smoker 45 40 26 25 41 40
 Current smoker 9 13 6 9 6 8
Unknown 0 4 2 1 7 7
Diagnosed hypertension (%) 29 23 12 9 19 19
Diagnosed hyperlipidemia (%) 30 28 5 12 21 21
Diagnosed diabetes (%) 5 4 0 2 1 3
Current statin users (%) 7 7 2 3 3 3

All values apart from age are age-adjusted to the distribution of the cohort. The calendar years were the starting points for follow-up in these analyses

BMI body mass index; HPFS health professionals follow up study; NHS nurses’ health study; NHSII nurses’ health study II; SD standard deviation